| Device |
neurovascular liquid embolic agent |
| Definition |
Arterial occlusion of the middle meningeal artery for treatment of symptomatic subdural hematoma. |
| Physical State |
Fluid |
| Technical Method |
The agent is delivered to the middle meningeal artery where it remains in place to occlude the artery and prevent further blood flow through the artery. |
| Target Area |
Middle meningeal artery |
| Review Panel |
Neurology |
| Product Code | SGU |
| Premarket Review |
Neurosurgical, Neurointerventional and Neurodiagnostic Devices
(DHT5A)
Neurosurgical, Neurointerventional and Neurodiagnostic Devices
(DHT5A)
|
| Submission Type |
PMA
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
Yes
|
| Life-Sustain/Support Device? |
Yes
|
| Third Party Review |
Not Third Party Eligible |